Close Menu

Prostate Cancer

News and reporting on prostate cancer.

The company has given the University of Michigan mass spec tools for prostate cancer research.

Over the past week, OGT acquired protein-array maker Sense Proteomic, Aushon bought Thermo's SearchLight protein-array business, and Gentel and Eprogen allied to help drug makers identify new autoantibody biomarkers.

OGT gains technologies for biomarker identification, which could be used for therapeutic monitoring.

IP Roundup: Mar 10, 2009

Premium

Accelr8, Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Stanford University, Aperio Technologies

The company last month presented data showing that the test could be used to detect cancer, but more work is needed to refine the test so that it can distinguish between different types of malignancies.

While its revenues were down for the quarter, CombiMatrix's full-year revenues increased 5 percent. The firm cautioned, however, that it only has enough cash to fund operations until September.

The data presented last week at the Molecular Medicine Tri-Conference showed that the investigational test detected "dramatically different" miRNA expression patterns in the blood of cancer patients compared to those who were cancer-free.

The Umbrella Institute

Premium

The Hunter Medical Research Institute was started to bring together biomedical and clinical scientists — and the results have been so positive that it has become a model for how to accomplish translational research.

Direct-to-consumer genetic testing companies have based their products on what scientists have accomplished, but the caveat is that the science is still in its early days.

Quest plans to develop and sell a diagnostic for prostate cancer based on the biomarker.

Pages

UK Royal Statistical Society is organizing a working group to develop guidelines for assessing COVID-19 tests, the Guardian reports.

The Washington Post reports that the White House chief of staff has asked the US Food and Drug Administration to justify the stricter standards it is seeking for a coronavirus vaccine.

President Donald Trump's "good genes" comment raises eugenics concerns, CNN reports.

In PLOS this week: genetic analysis of tremor condition, analysis of a West and Central African tree used in traditional medicine, and more.